

The TAS Branch would like to invite you to their 2023 Spring Meeting with a focus on deprescribing.
Expect to hear from local, influential speakers, engage in interactive workshops and put into practice those skills learnt during the recent deprescribing week.
Don’t miss this opportunity to network with local hospital pharmacists at the magnificent Grange Residence in the historical rural township of Campbell Town. The event will be followed by an inclusive BBQ lunch.
Presenters:
Dr Daniel Hoyle BPharm (hons,) Grad Cert Research, PhD, Lecturer in Therapeutics and Pharmacy Practice University of Tasmania
Dr. Daniel Hoyle is a Lecturer in Therapeutics and Pharmacy Practice in the School of Pharmacy and Pharmacology at the University of Tasmania and a practising accredited pharmacist. His research is focused on implementing and evaluating interventions to enhance the quality use of medicines in older people, particularly through deprescribing. He is also leading research to explore pharmacogenetic-informed approaches to improve the safety of medication withdrawal. Dr Hoyle is an elected member of the Australian Deprescribing Network Executive Committee and was recently awarded a position in the Junior Investigator Intensive Program with the US Deprescribing Research Network.
Dr Pankti Shastri, BPharm (hons,) PhD, Lecturer in Therapeutics and Pharmacy Practice University of Tasmania, Clinical Pharmacist, Launceston General Hospital
Pankti is a pharmacist with a wealth of experience across the Tasmanian health sector. She has worked in community pharmacy, hospital pharmacy and educating pharmacy students, as a lecturer at the University of Tasmania. She has a particular interest in deprescribing, with a focus on drug related problems in aced-care practice and opioid deprescribing in the community.
The program addresses pharmacist competency standards, including:
Standard 1.1.1 Promote a culture of professionalism
Standard 1.1.2 Uphold the professional role of a pharmacist
Standard 1.1.3 Apply understanding and knowledge of medicines management and use in society
Standard 1.1.4 Accept professional responsibility and accountability
Standard 1.2.1 Support ethical professional practice
Standard 1.2.2 Manage ethical issues arising in practice
Standard 1.2.3 Promote ethical professional practice
Standard 1.3.3 Respect and protect the individual’s rights to privacy and confidentiality
Standard 1.4.3 Acquire and apply practice expertise
Standard 1.6.1 Collaborate to improve quality and safety across the continuum of care
Standard 2.1.2 Support and respect the rights of patients and other clients to contribute to decision-making
Standard 2.1.4 Consider the impact of the physical environment
Standard 2.2.1 Show a commitment to interprofessional practice
Standard 2.3.1 Use appropriate communication skills
Standard 2.4.1 Analyse the problem or issue to be addressed and the possible solutions
Standard 3.1.2 Assess medication management practices and needs
Standard 3.1.3 Collaborate to develop a medication management strategy or plan
Standard 3.2.2 Provide primary care and promote judicious use of medicines
Standard 3.2.5 Provide counselling and information for safe and effective medication management
Standard 3.6.1 Assist development of health literacy
Standard 4.3.3 Encourage, influence and facilitate change’
(National Competency Standards Framework for Pharmacists in Australia, 2016)
Accreditation
This activity has been accredited for 3.5 hours of Group-2 CPD (or 7 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan.
The accreditation number for your reference is S2023/66
All registration rates include GST
SHPA are in no way responsible for any connectivity issues as a result of the participants internet connection or hardware issues or other external factors impacting the internet, that are out of SHPA’s control.
The SHPA website contains guidelines, policies, procedures, information and various data which have been prepared by SHPA. Whilst the information contained on this site has been reviewed with due care, SHPA does not warrant or imply that the information is free from errors or omissions. Whilst the information is considered to be true and correct at the date of publication, changes in circumstances after publication may impact on the accuracy of the information.
The information presented on the website is made available on the understanding that SHPA, its employees and agents shall have no liability to the users for any loss, damage, cost or expenses arising from the use of the information through either action or inaction based on material on this site.
SHPA provides links from the SHPA website to sites that might be useful information sources to users of the website. Providing this information in no way assumes responsibility for the content contained on those websites.
Members | |||
---|---|---|---|
SHPA Member |
SHPA Member Available Until 20/09/23 |
$90.00 | |
SHPA Member: Pharmacy student/intern/technician full-day |
SHPA Member Pharmacy Student/Pharmacy Intern Available Until 18/09/23 |
$60.00 | |
Non-Members | |||
SHPA non-member |
SHPA non-member Available Until 20/09/23 |
$110.00 | |
SHPA Non-member: Pharmacy student/intern/technician full-day |
SHPA non-member Pharmacy Student/Intern Available Until 18/09/23 |
$80.00 |